Congyi Xie

Congyi Xie

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2025 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
JCJinzhan Chen
Jinzhan Chen
ACAyun Chen
Ayun Chen
SYShuwen Yang
Shuwen Yang
FZFuhan Zhang
Fuhan Zhang
HJHongni Jiang
Hongni Jiang
CXCongyi Xie
Congyi Xie
The impact of insulin resistance (IR) on chronic obstructive pulmonary disease (COPD) has caught increasing attention, and the triglyceride-glucose (TyG) index and related indices are deemed reliable indicators for evaluating IR. Nevertheless, the potential associations of TyG and obesity-related indexes with COPD are currently understudied. Hence, this paper was to inspect the links of TyG and obesity-related indices with COPD. This was a cross-sectional study based on data from the NHANES 2013–2018. Weighted logistic regression (WLR), restricted cubic sample (RCS), and receiver operating characteristic (ROC) curves were leveraged to examine the links of the TyG index and obesity indices with COPD. The stability of the correlations was also assessed via subgroup analyses. Data from 6383 participants were finally included, including 583 patients with COPD. WLR discovered positive associations of TyG, TyG-body mass index (TyG-BMI), TyG-waist circumference (TyG-WC), and TyG-waist height ratio (TyG-WHtR) with COPD regardless of covariate adjustment (p-value < 0.05, p for trend test < 0.05). After adjusting for all confounders, RCS analysis signaled notable linear links of TyG and obesity-related indices with COPD (p-value < 0.05, p for nonlinear > 0.05). TyG-WHtR showed the highest association with COPD among the indices tested, albeit with limited discriminative ability (AUC = 0.643, 95% CI: 0.619 ~ 0.665). Subgroup analyses further validated the stability and reliability of the results. TyG and its combination with obesity-related indicators are associated with COPD. Among these, TyG-WHtR showed the strongest association with COPD, although causal relationships cannot be inferred and its discriminative ability remained modest. Further prospective studies are warranted to validate these findings. Not applicable.

1 August 2025 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
JCJinzhan Chen
Jinzhan Chen
ACAyun Chen
Ayun Chen
NZNing Zhang
Ning Zhang
ZCZhisheng Chen
Zhisheng Chen
JHJinxian Huang
Jinxian Huang
CXCongyi Xie
Congyi Xie
Background: Co-morbidity of chronic obstructive pulmonary disease (COPD) and type 2 diabetes mellitus (T2DM) corresponds to increasing severity and adverse clinical outcomes. This study intends to investigate the association of stress hyperglycemia ratio (SHR) with adverse outcomes in critically ill patients with COPD and T2DM. Methods: Critically ill patients diagnosed with COPD and T2DM from 2008 to 2019 were retrospectively included from the Medical Information Mart for Intensive Care IV (MIMIC-IV; version 2.2). They were assigned into three groups based on SHR tertiles, and all-cause in-hospital mortality (ACIHM) and length of intensive care unit (ICU) stay (LOIS) were the primary and secondary outcomes, respectively. The association of SHR with adverse outcomes was explored by Logistic regression, generalized linear regression, and restricted cubic spline (RCS) curve analyses, and its robustness was verified by subgroup analyses. Results: Totally 1,781 patients with COPD and T2DM were included. Logistic regression analyses revealed that after adjusting for all confounders, the risk of ACIHM increased by 51% in T3 compared with T1 [odds ratio (OR) =1.51; 95% confidence interval (CI): 1.06–2.16]. RCS curve analyses showed a statistically significant linear association between SHR and ACIHM (Pnonlinear=0.58). As shown by generalized linear regression analyses, each unit increase in SHR was associated with a 0.68-day increase in LOIS after adjusting for all confounders (β=0.68; 95% CI: 0.12–1.2). According to subgroup analyses, SHR and ACIHM had no statistically significant interaction except for the marital status subgroup (Pinteraction=0.04). Conclusions: A high SHR is associated with an increase in ACIHM and LOIS in critically ill patients with COPD and T2DM. Assessment of SHR may contribute to better risk stratification and prognostic prediction for such patients.

15 October 2025 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
JCJinzhan Chen
Jinzhan Chen
ZCZhisheng Chen
Zhisheng Chen
SYShuwen Yang
Shuwen Yang
HJHongni Jiang
Hongni Jiang
CXCongyi Xie
Congyi Xie
Prolonged hospital stay in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) significantly impacts patient outcomes and healthcare resource allocation. This study aimed to develop and validate an interpretable machine learning (ML) model for forecasting prolonged hospital stays of the AECOPD population. A retrospective analysis was performed utilizing data from the MIMIC-IV database on patients diagnosed with AECOPD. The dataset was split into a training set (80%) and a validation set (20%). Feature selection was executed through LASSO regression and the Boruta algorithm. Logistic regression (LR), random forest (RF), neural network (NN), gradient boosting machine (GBM), naive Bayes (NB), as well as K-nearest neighbors (KNN) models were constructed based on the selected features. Model performance was evaluated via receiver operating characteristic (ROC), calibration and decision curves. The interpretability of the optimal model was enhanced through SHapley Additive exPlanations (SHAP) analysis. 7,373 AECOPD patients were encompassed. The final model incorporated the following features: hemoglobin, platelet count, anion gap, blood urea nitrogen(BUN), potassium, chloride, antibiotic use, invasive ventilation, vasopressor use, SOFA, body temperature(Tb), heart rate(HR), acute kidney injury (AKI), as well as sepsis. The RF model demonstrated the best predictive performance, with an area of the ROC curve (AUC) of 0.817 in the training set and 0.715 in the validation set, along with good calibration and clinical utility. SHAP analysis further enhanced the interpretability of the model, providing valuable clinical decision support. The RF model developed in our study exhibited excellent performance in predicting prolonged hospital stays in AECOPD patients. The incorporation of interpretability analysis improved the transparency and reliability of its clinical application. Not applicable.

11 April 2026 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
JLJiaxin Liu
Jiaxin Liu
JCJinzhan Chen
Jinzhan Chen
JLJianying Liu
Jianying Liu
XXXiong Xiao
Xiong Xiao
HCHaiyan Chen
Haiyan Chen
CXCongyi Xie
Congyi Xie
The C-reactive protein-to-albumin ratio (CAR) reflects systemic inflammation and malnutrition, but its association with survival in anlotinib-treated advanced non-small cell lung cancer (NSCLC) remains unexplored. We retrospectively analyzed 417 patients with stage IIIB-IV NSCLC treated with anlotinib at Zhongshan Hospital, Fudan University and Zhongshan Hospital (Xiamen), Fudan University. Baseline CAR was calculated as serum C-reactive protein (mg/L) divided by albumin (g/L). Overall survival (OS) was defined as the time from treatment initiation to death or last follow-up. Cox proportional hazards models, restricted cubic spline (RCS) analysis, and two-piecewise linear regression model were applied to evaluate the association between CAR and OS. Subgroup analyses were further performed for robustness. Among 417 patients (mean age 62.2 ± 10.33 years), 216 deaths (51.8%) occurred during follow-up. The median CAR was 0.34 (0.08–1.09). In multivariable Cox models, elevated CAR was independently associated with worse OS (HR 1.10, 95% CI 1.01–1.21, p = 0.031). RCS analysis revealed a nonlinear association between CAR and OS (p for nonlinearity < 0.001). The inflection point was 2.12: below this threshold, higher CAR significantly increased mortality risk (HR 1.92, 95% CI 1.54–2.40, p < 0.0001), whereas above 2.12, CAR showed a non-significant trend toward lower risk (HR 0.82, 95% CI 0.68–1.00, p = 0.050). Subgroup analyses demonstrated consistent associations across most clinical strata. Baseline CAR is a strong and independent prognostic marker for OS in advanced NSCLC patients treated with anlotinib. Its simplicity and availability make it a valuable tool for clinical risk stratification and treatment planning.

19 July 2026 in BMC Cancer
Verified
Journal Article
Open access
PDF file
NZNing Zhang
Ning Zhang
ZLZhenyang Lin
Zhenyang Lin
JCJinzhan Chen
Jinzhan Chen
XXXiong Xiao
Xiong Xiao
JLJiaxin Liu
Jiaxin Liu
CXCongyi Xie
Congyi Xie
The albumin-to-alkaline phosphatase ratio (AAPR) has been reported as a prognostic biomarker in several malignancies, but its clinical relevance in advance